Global Blood Therapeutics, Inc. short interest in 2020
In 2020, Global Blood Therapeutics, Inc.'s disclosed short interest ran from 12.76% of shares outstanding on 15 Jan 2020 to 18.86% on 31 Dec 2020, a change of +6.10 percentage points. The year's high was 21.02% on 13 Nov 2020 and its low 11.98% on 31 Jan 2020, averaging 15.37% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 20.17 days on 31 Jul 2020. Full history: Global Blood Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022
2020 in figures
- Start of year
- 12.76% (15 Jan 2020)
- End of year
- 18.86% (31 Dec 2020)
- Change
- +6.10 pp
- High
- 21.02% (13 Nov 2020)
- Low
- 11.98% (31 Jan 2020)
- Average
- 15.37%
- Highest days to cover
- 20.17 (31 Jul 2020)
- SEC filings marked
- 8
Every report in 2020
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2020 | 12.76% | 9.13 | |
| 31 Jan 2020 | 11.98% | 7.89 | |
| 14 Feb 2020 | 12.01% | 13.00 | |
| 28 Feb 2020 | 12.28% | 9.12 | 10-K filed, results (8-K) |
| 13 Mar 2020 | 12.93% | 7.88 | |
| 31 Mar 2020 | 15.85% | 8.79 | |
| 15 Apr 2020 | 16.77% | 11.25 | |
| 30 Apr 2020 | 15.69% | 10.93 | |
| 15 May 2020 | 15.23% | 9.65 | 10-Q filed, results (8-K) |
| 29 May 2020 | 15.69% | 18.88 | |
| 15 Jun 2020 | 16.67% | 14.71 | |
| 30 Jun 2020 | 15.22% | 6.91 | |
| 15 Jul 2020 | 14.77% | 13.29 | |
| 31 Jul 2020 | 15.44% | 20.17 | |
| 14 Aug 2020 | 14.82% | 11.03 | 10-Q filed, results (8-K) |
| 31 Aug 2020 | 14.30% | 19.90 | |
| 15 Sep 2020 | 14.63% | 9.71 | |
| 30 Sep 2020 | 15.10% | 12.68 | |
| 15 Oct 2020 | 15.16% | 12.43 | |
| 30 Oct 2020 | 15.57% | 14.15 | |
| 13 Nov 2020 | 21.02% | 3.92 | 10-Q filed, results (8-K) |
| 30 Nov 2020 | 18.81% | 11.64 | |
| 15 Dec 2020 | 17.40% | 7.48 | |
| 31 Dec 2020 | 18.86% | 13.24 |
See also: Global Blood Therapeutics, Inc.'s full history · most shorted US stocks of 2020 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.